The outcome of ciliary body ablation with diode laser contact transscleral cyclophotocoagulation in 6 months follow-up.

Weronika Mularska, A. Brązert, J. Kocięcki
{"title":"The outcome of ciliary body ablation with diode laser contact transscleral cyclophotocoagulation in 6 months follow-up.","authors":"Weronika Mularska, A. Brązert, J. Kocięcki","doi":"10.24292/01.ot.300922.5","DOIUrl":null,"url":null,"abstract":"The aim of the study is to analyse the postoperative results of continuous wave, transscleral cyclophotocoagulations (CW-TSCPC) in 6 months follow-up for patients with refractory glaucoma. \nMaterial and methods: We retrospectively reviewed 58 records of patients who underwent the transscleral cyclophotocoagulation because of refractory glaucoma at the Department of Ophthalmology, Poznan University of Medical Sciences, Poland, between 2016 and 2022. All patients underwent ophthalmological examination at baseline and during follow-up visits including best-corrected visual acuity, intraocular pressure measurement (IOP), slit-lamp examination, visual field and optical coherence tomography examination of the retinal nerve fiber layer (OCT RNFL). Follow-up time was 6 months. \nResults: We analyzed a group of 58 patients (28 women and 30 men, average age of 62). Majority of patients (41 eyes, 70.69%) had secondary open angle glaucoma. There were no serious complications of the CW-TSCPC procedure. We achieved IOP normalization (IOP below 22 mmHg) in 81.03% of eyes in 1 month follow-up, in 81.08% after 2 months, and in 72.41% after 6 months. Mean IOP reduction was 53.47%, 47.71%, and 47.65% from baseline at 1, 2, and 6 months, respectively. The number of medications taken by patients was lowered of 74.14%, 70.27% and 68.97% after 1, 2 and 6 months respectively. 17 eyes (29.31%) required additional surgical interventions within 6 months. \nConclusions: CW-TSCPC is an effective and safe procedure. It allows lowering of IOP and reduction of drugs number administrated by patients with various types of glaucoma during 6 months follow-up. The procedure is technically easy and with well-controlled postoperative complications.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"87 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OphthaTherapy. Therapies in Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24292/01.ot.300922.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of the study is to analyse the postoperative results of continuous wave, transscleral cyclophotocoagulations (CW-TSCPC) in 6 months follow-up for patients with refractory glaucoma. Material and methods: We retrospectively reviewed 58 records of patients who underwent the transscleral cyclophotocoagulation because of refractory glaucoma at the Department of Ophthalmology, Poznan University of Medical Sciences, Poland, between 2016 and 2022. All patients underwent ophthalmological examination at baseline and during follow-up visits including best-corrected visual acuity, intraocular pressure measurement (IOP), slit-lamp examination, visual field and optical coherence tomography examination of the retinal nerve fiber layer (OCT RNFL). Follow-up time was 6 months. Results: We analyzed a group of 58 patients (28 women and 30 men, average age of 62). Majority of patients (41 eyes, 70.69%) had secondary open angle glaucoma. There were no serious complications of the CW-TSCPC procedure. We achieved IOP normalization (IOP below 22 mmHg) in 81.03% of eyes in 1 month follow-up, in 81.08% after 2 months, and in 72.41% after 6 months. Mean IOP reduction was 53.47%, 47.71%, and 47.65% from baseline at 1, 2, and 6 months, respectively. The number of medications taken by patients was lowered of 74.14%, 70.27% and 68.97% after 1, 2 and 6 months respectively. 17 eyes (29.31%) required additional surgical interventions within 6 months. Conclusions: CW-TSCPC is an effective and safe procedure. It allows lowering of IOP and reduction of drugs number administrated by patients with various types of glaucoma during 6 months follow-up. The procedure is technically easy and with well-controlled postoperative complications.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经巩膜激光接触睫状体消融6个月随访结果分析。
本研究的目的是分析难治性青光眼患者术后连续波经巩膜光凝治疗(CW-TSCPC) 6个月的随访结果。材料和方法:我们回顾性分析了2016年至2022年波兰波兹南医科大学眼科收治的58例难治性青光眼患者经巩膜光凝治疗的记录。所有患者在基线和随访期间均接受眼科检查,包括最佳矫正视力、眼内压测量(IOP)、裂隙灯检查、视野和视网膜神经纤维层光学相干断层扫描(OCT RNFL)。随访6个月。结果:我们分析了58例患者(女性28例,男性30例,平均年龄62岁)。继发性开角型青光眼占多数(41眼,70.69%)。CW-TSCPC手术无严重并发症。随访1个月后,81.03%的眼实现IOP正常化(IOP低于22 mmHg),随访2个月后达到81.08%,随访6个月后达到72.41%。在1、2和6个月时,平均IOP分别比基线降低53.47%、47.71%和47.65%。1个月、2个月和6个月后患者服药次数分别下降74.14%、70.27%和68.97%。17只眼(29.31%)在6个月内需要额外的手术干预。结论:CW-TSCPC是一种安全有效的手术方法。在6个月的随访中,不同类型青光眼患者可降低IOP,减少药物用量。手术技术简单,术后并发症控制良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
0
期刊最新文献
Malignant glaucoma: disease course and treatment Efficacy of oral steroid therapy in the treatment of acute maculopathy in the course of hand, foot and mouth disease – 3 case reports When a large refractive defect is found in a child, should electroretinography be ordered immediately? Corneal biomechanical changes after myopic and hyperopic laser vision correction Diagnosis and treatment of corneal ulcers in the course of systemic autoimmune diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1